(Press-News.org) Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.
“The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Giovanni Traverso, the first author of the paper, associate professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology and gastroenterologist at Brigham and Women’s Hospital.
In recent years, scientists have been developing a plethora of ingestible devices. Unlike implantable devices such as pacemakers, ingestible devices are easy to use and do not require a surgical procedure. For example, doctors have been using pill-sized ingestible cameras to conduct colonoscopies, a procedure traditionally conducted in a hospital setting.
“The idea of using an ingestible device is that a physician can prescribe these capsules, and all the patient needs to do is to swallow it,” says Benjamin Pless, the paper’s co-author and the founder of the Celero Systems, a medical device developer based in Massachusetts. “People are accustomed to taking pills, and costs of using ingestible devices are much more affordable than performing traditional medical procedures.”
The vitals-monitoring pill, or VM Pill, works by monitoring the small vibrations of the body associated with breathing and the beating heart. The pill can detect if a person stops breathing from the inside of the digestive tract.
To test out the VM Pill, the team placed the device in the stomach of pigs which were put under anesthesia. Researchers then administered the pigs with a dose of fentanyl that caused the pig to stop breathing, which is what happens during fentanyl overdose in humans. The device measured the pig’s breathing rate in real time and alerted the researchers, who were able to reverse the overdose.
The team also tested the device in humans for the first time by giving the VM Pill to those being evaluated for sleep apnea. Sleep apnea is a disorder in which breathing repeatedly stops and starts during sleep. Many people with the condition remain undiagnosed, in part because diagnosing the condition involves admitting people to a sleep laboratory where they are hooked up to external devices to monitor their vital signs during sleep.
“Given our interest in opioid safety, it came to our attention that sleep apnea has a lot of the same symptoms as opioid-induced respiratory depression,” says Pless.
Researchers gave the VM Pill to 10 patients with sleep apnea at West Virginia University. The device was able to detect when the participants’ breathing stopped and to monitor respiration rate with an accuracy of 92.7%. Compared with external vital monitoring machines, the pill can monitor heart rate with an accuracy of at least 96%. The trial also showed the device is safe, and all participants excreted the device in the few days after the experiment.
“The accuracy and correlation of these recordings were excellent compared to the clinical gold standard studies we performed in our sleep laboratories,” says Ali Rezai, the paper’s co-author and a neuroscientist at the Rockefeller Neuroscience Institute, West Virginia University. “The ability to remotely monitor critical vital signals from patients without wires, leads, or need of medical technicians, opens the door for monitoring patients in their natural environments versus the clinic or the hospital setting,” he adds.
Traverso says the current version of the VM Pill passes through the body in about a day, but there are modifications they can make to the device in the future that would allow it to stay longer for long-term monitoring. In the future, they also hope to upgrade the device so it can deliver drugs to reverse conditions like opioid overdose automatically once the device detects symptoms.
“In the future, there are many situations, including opioid overdose and other respiratory and cardiac conditions, that could certainly benefit from this ingestible device,” Traverso says.
Conflict of interest information: Authors Daniel Bacher, Shannon Schuetz, and Benjamin Pless are employees of Celero Systems, Inc. Robert Langer and Giovanni Traverso have a financial interest in Celero Systems, Inc. Ali Rezai is an advisor to Celero Systems, Inc. Daniel Bacher and Benjamin Pless are co-inventors on published patent applications (US20210060317, EP4021271) encompassing the work described. Benjamin Pless and Giovanni Traverso are members of the Board of Directors for Celero Systems, Inc. Please see the paper for more information.
Device, Traverso et al., “First-in-human trial of an ingestible vitals monitoring pill” https://cell.com/device/fulltext/S2666-9986(23)00184-9
Device (@Device_CP), is a physical science journal from Cell Press along with Chem, Joule, and Matter. Device aims to be the breakthrough journal to support device- and application-oriented research from all disciplines, including applied physics, applied materials, nanotechnology, robotics, energy research, chemistry, and biotechnology under a single title that focuses on the integration of these diverse disciplines in the creation of the cutting-edge technology of tomorrow. Visit http://www.cell.com/device/home. To receive Cell Press media alerts, contact email@example.com.
What if, instead of going into a sleep lab or being connected to monitoring devices, a patient could have their risk of obstructive sleep apnea measured by swallowing a pill? A new collaborative study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, Massachusetts Institute of Technology, Celero Systems and West Virginia University, evaluated a wireless ingestible device that can accurately report vital signs like heart and respiratory rate. The team tested the device, known as the Vitals Monitoring Pill (VM Pill), in a pilot ...
Bio-based plastics such as polylactic acid (PLA) were invented to help solve the plastic waste crisis, but they often end up making waste management more challenging. Because these materials look and feel so similar to conventional, petroleum-based plastics, many products end up not in composters, where they break down as designed, but instead get added to the recycling stream by well-intentioned consumers. There, the products get shredded and melted down with the recyclable plastics, bringing down the quality of the mixture and making it harder to manufacture functional products out of recycled plastic resin. The only solution, currently, is to try to separate the different ...
CAMBRIDGE, MA -- Diagnosing sleep disorders such as sleep apnea usually requires a patient to spend the night in a sleep lab, hooked up to a variety of sensors and monitors. Researchers from MIT, Celero Systems, and West Virginia University hope to make that process less intrusive, using an ingestible capsule they developed that can monitor vital signs from within the patient’s GI tract.
The capsule, which is about the size of a multivitamin, uses an accelerometer to measure the patient’s breathing rate and heart rate. In addition to diagnosing sleep apnea, the device could also be useful for detecting ...
About The Study: Among outpatient adults with mild to moderate COVID-19, treatment with fluvoxamine 100 mg twice daily for 13 days, compared with placebo, did not improve time to sustained recovery in this randomized clinical trial of 1,175 participants.
Authors: Susanna Naggie, M.D., M.H.S., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, ...
About The Study: In this study of 155,000 births, using a causal inference framework based on target trial emulation, birth at 39 weeks’ gestation was not associated with adverse numeracy and literacy outcomes at school age compared with birth at 40 to 42 weeks.
Authors: Roxanne Hastie, Ph.D., of the University of Melbourne, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for ...
About The Study: In this study of state laws, there was substantial heterogeneity in National Instant Criminal Background Check System (NICS) reporting requirements for mental health prohibitions for firearm possession and a lack of clarity around processes. This raises questions about the ability of NICS to be used to block firearm purchases or possession by individuals with court-identified high risk of perpetrating violence toward themselves or others.
Authors: Marian E. Betz, M.D., M.P.H., of the University of Colorado Anschutz Medical Campus School of Medicine in Aurora, is the ...
There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life. However, when researchers adjusted for familial factors by means of sibling analysis, they found a weaker association, although the link between high body mass index (BMI) and cardiovascular disease remained strong. The study, which was conducted by researchers from Karolinska Institutet and other universities, is published in JAMA Network Open.
“This does not mean that fitness is irrelevant,” ...
Old people who follow a Mediterranean diet are at a lower risk of cognitive decline, according to a study published in the journal Molecular Nutrition and Food Research. The study provides new evidence for a better understanding of the biological mechanisms related to the impact of the diet on cognitive health in the ageing population.
The study is led by Mireia Urpí-Sardá, adjunct lecturer and member of the Biomarkers and Nutritional & Food Metabolomics research group of the Faculty of Pharmacy and Food Sciences, the Institute for Nutrition and Food Safety (INSA-UB), the Food and Nutrition Torribera Campus of the University of Barcelona, and the CIBER on Frailty and ...
The vision system, evolved over millions of years, is highly complex. To make vision sensitive throughout the whole range of visible wavelengths, Nature employs a supramolecular chemistry approach. The visual pigment, cis-retinal, changes its shape upon capturing a photon. This shape transformation is accompanied by changes in the supramolecular organization of the surrounding proteins, subsequently triggering a cascade of chemical signaling events that get amplified and eventually lead to visual perception in the brain.
“Some deep-sea fish have evolved antenna-like ...
The remarkable proton and oxide-ion (dual-ion) conductivities of hexagonal perovskite-related oxide Ba7Nb3.8Mo1.2O20.1 are promising for next-generation electrochemical devices, as reported by scientists at Tokyo Tech. The unique ion-transport mechanisms they unveiled will hopefully pave the way for better dual-ion conductors, which could play an essential role in tomorrow’s clean energy technologies.
Clean energy technologies are the cornerstone of sustainable societies, and solid-oxide fuel cells (SOFCs) and proton ceramic fuel cells (PCFCs) are among the most promising types of electrochemical devices for green power generation. These devices, however, still ...